Philadelphia, PA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)The Institute For Cancer Research, founded in 1944, is a mid-sized nonprofit in the Medical Research sector that reported $94.5M in total revenue in fiscal year 2024. Expenses of $104.4M exceeded revenue, resulting in a 10% operating deficit.
To prevail over cancer, marshaling heart and mind in bold scientific discovery, pioneering prevention and compassionate care.
The Institute for Cancer Research and its Research programs are renowned world-wide for their work in understanding both normal and abnormal cell growth. Scientists are involved in studies of genes...
The Institute for Cancer Research and its Research programs are renowned world-wide for their work in understanding both normal and abnormal cell growth. Scientists are involved in studies of genes that cause or inhibit cancer growth, virology, immunology, chemical carcinogens, cell growth and interaction and gene expression. In recent years, research has increasingly emphasized molecular oncology and genetics, areas which bridge advancing knowledge from the laboratory with new clinical approaches.
The research facilities have been structured to fulfill the needs of the multi-disciplinary research programs at Fox Chase Cancer Center. The facilities have been designed to enhance ongoing research...
The research facilities have been structured to fulfill the needs of the multi-disciplinary research programs at Fox Chase Cancer Center. The facilities have been designed to enhance ongoing research by supplying information, reagents, and technical expertise that are not readily available to the individual investigator.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $94,545,853 | $98,007,791 | 0.0% |
| Expenses | $104,429,815 | $97,174,266 | +0.1% |
| Net Income | $-9,883,962 | $833,525 | -12.9% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Lewis Gould | Director | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Chip W Marshall III | Director/Chair | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Christopher McNichol | Director/Vice Chair | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Michael Young | Director | 1.00 |
Director
|
$0 | $42,028 | $2,136,271 |
| Amy Goldberg | Director | 1.00 |
Director
|
$0 | $55,526 | $1,215,526 |
| Tina Pidgeon | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Dr Solomon Luo | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Edward Glickman | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Thomas Hofmann | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| David Marshall | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Dr Donald Morel | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| William Federici | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Sandra Harmon-Weiss | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Leon O Moulder | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Carl Sottosanti | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Dr Robert Uzzo | President & CEO | 1.00 |
Officer
|
$0 | $72,823 | $1,582,504 |
| John Ryan | Asst Secretary | 1.00 |
Officer
|
$0 | $50,704 | $891,282 |
| Tausha Saunders | Asst Secretary | 1.00 |
Officer
|
$0 | $375 | $190,321 |
| Amy Montour | Asst Secretary | 1.00 |
Officer
|
$0 | $0 | $17,848 |
| Jerome Maddox | Secretary | 1.00 |
Officer
|
$0 | $43,833 | $534,746 |
| Jarred Matchett | Treasurer & CFO | 1.00 |
Officer
|
$0 | $44,907 | $471,837 |
| Michael DiFranco | Asst Treasurer | 1.00 |
Officer
|
$0 | $50,978 | $433,239 |
| Timothy Cyphers | Asst Treasurer | 1.00 |
Officer
|
$0 | $36,273 | $202,273 |
| Jonathan Chernoff | Cancer Center Director | 49.00 |
Key Emp
|
$858,027 | $69,278 | $927,305 |
| David Wiest | Chief Scientific Officer | 50.00 |
Key Emp
|
$624,172 | $67,129 | $691,301 |
| Shawn Paul Kleitz | Chief Development Officer | 50.00 |
Key Emp
|
$353,203 | $46,769 | $399,972 |
| Michael Hall | Professor | 50.00 |
Highest
|
$493,347 | $58,446 | $551,793 |
| Elizabeth Plimack | Professor | 50.00 |
Highest
|
$491,320 | $66,529 | $557,849 |
| Siddharth Balachandran | Professor | 50.00 |
Highest
|
$489,366 | $53,926 | $543,292 |
| Carolyn Fang | Professor | 50.00 |
Highest
|
$347,572 | $27,856 | $375,428 |
| Mary Daly | Professor | 50.00 |
Highest
|
$328,309 | $46,174 | $374,483 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $94,545,853 | $104,429,815 | $191,981,593 | $-9,883,962 |
| 2024 | $98,007,791 | $97,174,266 | $182,653,136 | $833,525 |
| 2023 | $98,782,288 | $90,482,128 | $164,344,413 | $8,300,160 |
| 2022 | $98,184,142 | $89,809,102 | $147,654,259 | $8,375,040 |
| 2021 | $82,576,402 | $82,749,706 | $148,137,241 | $-173,304 |
| 2020 | $84,512,991 | $83,337,665 | $138,576,828 | $1,175,326 |
| 2019 | $83,025,248 | $83,115,501 | $142,695,790 | $-90,253 |
| 2018 | $97,662,344 | $80,390,149 | $136,111,873 | $17,272,195 |
Compare The Institute For Cancer Research with other nonprofits in Pennsylvania and across the country.